You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Sale Disclosure
Agarwal Arjun · SEC Form 4 · Filed Jul 13, 2026
Sale
Calculated transaction value
$480.2K
Agarwal Arjun Senior Vice President, Finance
ORKA
Oruka Therapeutics
ORKA
Transaction date
Jul 13, 2026
Public filing date
Jul 13, 2026
Filing lag
Filed same day
ORKA daily price context
Close on/before transaction
$84.56
Jul 13, 2026
First close after public filing
$87.47
Jul 14, 2026
30-day return after filing
+22.78%
Through Aug 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,656 shares @ $84.9
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000907654-26-000071
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$1M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA | Exercise | Jul 13, 2026 | $106.76K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Jul 13, 2026 | $50.14K |
| Oruka Therapeutics, Inc. ORKA | Sale | Jul 13, 2026 | $24.92K |
| Oruka Therapeutics, Inc. ORKA | Sale | Jul 13, 2026 | $315.37K |
| Oruka Therapeutics, Inc. ORKA Current | Sale | Jul 13, 2026 | $480.2K |
| Oruka Therapeutics, Inc. ORKA | Sale | Jul 13, 2026 | $25.69K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Jul 13, 2026 | $0 |
| Oruka Therapeutics, Inc. ORKA | Exercise | Jul 13, 2026 | $0 |